Skip to main content
. 2023 Jul 20;228(10):1318–1325. doi: 10.1093/infdis/jiad275

Figure 2.

Figure 2.

Effect of parenteral remdesivir on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral clearance. Left: Median SARS-CoV-2 oropharyngeal virus clearance profiles following remdesivir (darker/grey) and no study drug (lighter/green). Right: estimated treatment effects under the linear model (light with circle) and nonlinear model (dark with triangle). The thick lines show the 80% credible interval (CrI); the thin lines show the 95% CrI.